Page 4 - Les Meilleurs oncologues - TOP-652 des médecins

Le Dr Yahya Ozel a été formé dans la division d'élite de chirurgie hépato-bilio-pancréatique de l'université de Tokyo, apportant la précision japonaise aux cas oncologiques complexes.

• Plus de 30 ans d'expérience chirurgicale axée sur les techniques mini-invasives
• Certifié en endoscopie chirurgicale et en procédures robotiques avancées
• Membre de la faculté académique de l'université de Doğuş, formant les futurs chirurgiens
• Spécialisé dans les chirurgies des cancers hépatobiliaires, pancréatiques et colorectaux

Prof. Amit Tirosh is a senior endocrinologist and Head of the Neuroendocrine Tumors Service at Sheba Medical Center. He specializes in neuroendocrine tumors (NETs).

His work centers on hereditary NET syndromes. He is affiliated with the NIH in MEN1 research. He serves on an international VHL expert panel and helped write VHL management guidelines. He is the primary contact at Sheba’s multidisciplinary VHL clinic.

He leads the Endocrine Oncology Bioinformatics Lab. He collaborates with international teams, including the Weizmann Institute. He provides advanced NET care, including PRRT.

He earned his MD from the Hebrew University–Hadassah. He completed a residency at Assaf HaRofeh, an endocrinology fellowship at Rabin, and training at the NIH. He is board-certified in Endocrinology. He is a member of the Israeli Society of Endocrinology, the Endocrine Society, and the European Neuroendocrine Tumor Society. He has authored over 40 peer-reviewed papers, including in JAMA, Gastroenterology, and Radiology.

Dr. Shira Felder is a senior radiation oncologist. She focuses on gynecologic and urologic cancers. She has advanced expertise in VMAT, IMRT, SBRT, and gynecologic brachytherapy. She delivers precise treatment with fewer side effects.

She heads the Gynecologic Oncology Service at Sheba Medical Center. She is a senior physician in the Radiation Oncology Division. She earned her MD at Hadassah. She completed residency at Sheba and a fellowship in the Radiation Medicine Program at the University of Toronto and Princess Margaret Cancer Centre. She is board-certified in Radiation Oncology. She is a member of ESTRO, the Israeli oncology societies, the CPSO, and the CMA.

Her research covers brachytherapy patient safety. It also includes stereotactic ablative radiotherapy for stage I lung cancer. She has studied treatment delays in cervical cancer. She has examined vitamin D deficiency in oncology patients.

Dr. David Kuczer is a specialist in radio-oncology with many years of experience in cancer diagnosis and treatment. He offers fast access to precise radiotherapy based on current scientific standards.

He is a member of the Cancer Center at the Vienna Private Clinic. He presents each patient to the in-house tumor board. This allows an interdisciplinary discussion by an internationally renowned team and helps select the best treatment.

All radiation treatments are provided in close cooperation with Amethyst Radiotherapy at the Vienna Private Clinic.

Professor Dov Zippel is a general surgeon and surgical oncologist. He specializes in breast disease and melanoma. He leads the Meirav Breast Center at Sheba Medical Center. He also serves at the Ella Lemelbaum Institute for Immuno-Oncology. In 2025, Forbes Israel named him to its Best Doctors list.

Expertise: advanced care for benign and malignant breast tumors. Minimally invasive and breast-conserving surgery. Surgical treatment of melanoma and other skin cancers.

Accreditations: MD, Tel Aviv University. Residency in general surgery, Sheba Medical Center. Fellowship in surgical oncology, University of Calgary. Board-certified in general surgery and surgical oncology. Research includes intact breast lesion excision and perioperative BRAF inhibitors for stage III melanoma.

Dr. Einat Shacham‑Shmueli is a senior medical oncologist at the Gastrointestinal Clinic, Cancer Center, Sheba Medical Center. She treats cancers of the colon, stomach, and pancreas. She also manages metastatic disease. She uses precision diagnostics and biomarkers, systemic therapies, and radiotherapy. Care is provided within a multidisciplinary team.

She has authored more than 25 peer‑reviewed papers on GI oncology, tumor biology, and new treatments. Her work includes studies on stenting for malignant colonic obstruction. She serves as an investigator in international programs, including the NCI, the Radiation Therapy Oncology Group, and the Cancer Therapy Evaluation Program.

Education: MD, Tel Aviv University. Oncology residency, Tel Aviv Sourasky Medical Center. Advanced training in GI oncology, UCSF. Accreditations: Board certified in Oncology and Gastroenterology. Member, Israel Society of Oncology and Radiotherapy.

Prof. Zvi Cohen is Director of the Neurosurgery Department and the Neuro-Oncology Unit at Sheba Medical Center. He is a neurosurgeon and neuro-oncology expert. He was included in Forbes Israel’s Best Doctors 2025. He leads clinical research on drug therapies for malignant brain tumors. He also founded Sheba’s brain tumor tissue bank.

He is board-certified in neurosurgery. He trained at Tel Aviv University. He completed fellowships in neuroradiology at Beth Israel and in neurosurgical oncology at MD Anderson. His practice covers complex brain, pituitary, spine, and spinal cord tumors. He has expertise in stereotactic biopsies, image-guided resections, intraoperative MRI, navigation systems, and radiosurgery. He is a member of the Society for Neuro-Oncology and the Israeli Association of Neurological Surgeons.

Le Dr Altay Aliyev associe des thérapies ciblées et l'immunothérapie à des protocoles fondés sur la recherche à l'hôpital Liv Bona Dea de Bakou.

• Formé à la Cleveland Clinic et à l'université d'Istanbul
• A publié plusieurs études sur les traitements du cancer de la thyroïde et du sein
• Expert en chimiothérapie cytotoxique et en hormonothérapie
• Se concentre sur le diagnostic précoce et les soins palliatifs

Dr. Almog Ben-Yaacov is an Attending Surgeon in the Department of General and Oncological Surgery (Surgery C) at Sheba Medical Center. He specializes in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). His clinical focus includes gastric cancer, sarcoma, and complex colorectal malignancies. Since 2018, he has performed more than 200 HIPEC procedures.

MD, Semmelweis University, 2006, with honors. Training in cardiothoracic surgery at Sheba Medical Center. Residency in general surgery at Montefiore (Albert Einstein) and at Rabin (Beilinson). Board-certified in General Surgery and in Surgical Oncology.

Advanced training includes ESSO-certified HIPEC in Hamburg. Microwave liver ablation in Reims. NanoKnife at King’s College London. Advanced surgical oncology at Memorial Sloan Kettering (2019). His publications cover CRS+HIPEC outcomes and Hartmann’s reversal.

Spécialiste des thérapies ciblées contre le cancer et de l'immunothérapie – Le Pr. agrégé Mutlu combine des traitements avancés avec une recherche génétique de pointe au Medical Park Antalya.

• Formé en oncologie médicale à l'Université d'Akdeniz et aux États-Unis
• Expert en plans de traitement personnalisés contre le cancer
• Professeur agrégé avec de vastes contributions académiques
• Pratique la médecine complémentaire aux côtés des traitements conventionnels

Le Dr Aydogdu est spécialisé dans la détection précoce du cancer chez les enfants, un aspect critique de l'oncologie pédiatrique.

• Se concentre sur les présentations et les discussions concernant la détection du cancer pédiatrique
• Travaille à l'hôpital Liv Bona Dea de Bakou
• Contribue aux progrès de l'oncologie pédiatrique

Le professeur associé Abdullah Sakin dirige le service d'oncologie médicale de l'hôpital Medipol Bahçelievler, spécialisé dans les cas de cancer complexes.

• Chef de l'oncologie médicale à l'université Yüzüncü Yıl
• Formé à l'hôpital de formation et de recherche d'Istanbul Okmeydanı
• Spécialisé dans le sarcome d'Ewing et d'autres cancers rares
• Vaste expérience dans les contextes académiques et cliniques

Spécialisée dans les traitements intégratifs du cancer au Biological Medicine - Integrative Health Center Baku, combinant la thérapie par le gui et la vitamine C à haute dose avec les méthodes conventionnelles.

• Experte en traitements hormonaux pour le cancer du sein
• Compétente dans la gestion des effets secondaires de la chimiothérapie et de la radiothérapie
• Participante à des conférences internationales avec des médecins allemands et turcs
• Utilise des méthodes naturelles de soulagement de la douleur et de prolongation de la vie pour les patients cancéreux

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

Chef du service de radio-oncologie au German Oncology Center – spécialisé dans les techniques de radiothérapie interventionnelle pour un ciblage précis du cancer.

• Doctorat de l'Université Johann Wolfgang Goethe
• Plus de 14 ans d'expérience en radio-oncologie
• Expert en curiethérapie et traitements de radiothérapie avancés
• Combine expertise clinique et formation en gestion de la santé

Spécialiste de la radiothérapie de pointe pour le cancer de la prostate – Le Dr Zamboglou dirige la recherche à l'Université de Fribourg et a remporté le prix Herman-Holthusen.

• Certifié en radiothérapie avec plus de 10 ans d'expérience
• Expert invité pour les directives allemandes et européennes sur le cancer de la prostate
• Directeur médical adjoint au German Medical Institute (GMI)
• Nombreuses publications sur les techniques de radiation de précision

Dr. Osama Abdel Mohimen Mohamed is Head of the Hematology Unit at Shefaa Al Orman Oncology Hospitals. He is also a consultant in medical oncology and hematology at Shefa El Orman Hospital (NGO), Luxor (2019–present).

He diagnoses and treats acute and chronic leukemia, lymphoma, myeloma, myelodysplastic syndromes, and myeloproliferative neoplasms. He also manages complications of solid tumors.

Background: He served at the National Cancer Institute, Cairo University, as a medical oncology resident, then demonstrator and assistant lecturer (2008–2022). Earlier, he was a house officer (2006–2007). He also held specialist roles at Al Salam International, Al Molalmen, and BAHEYA Oncology Center (NGO).

Memberships: ESMO (2008–present). American Society of Bone Marrow Transplantation (2009). ASH (2010).

Oncologue pédiatrique primé, spécialisé dans les sarcomes des os et des tissus mous à l'Hôpital pour enfants SJD de Barcelone – l'un des meilleurs hôpitaux pour enfants d'Europe.

• Dirige le département d'hématologie-oncologie et le laboratoire des tumeurs du développement
• A mis au point un traitement sans radiation pour les gliomes de la moelle épinière
• Formé au Memorial Sloan Kettering Cancer Center en oncologie pédiatrique
• A publié plus de 70 articles sur les tumeurs malignes chez l'enfant
• Lauréat de plusieurs prix internationaux pour la recherche sur le cancer pédiatrique

Le Dr Sinan Karaaslan a pratiqué plus de 900 interventions, se spécialisant dans les cancers du sein, colorectaux et urogénitaux au centre médical Anadolu.

• Certifié en oncologie médicale avec plus de 15 ans d'expérience ciblée
• Membre de la Société turque d'oncologie médicale et de la Société du cancer du poumon
• Formation spécialisée (Fellowship) à la faculté de médecine Cerrahpaşa de l'université d'Istanbul
• Expert en immunothérapie et en thérapies ciblées pour les cas complexes